(1)
Alobaidi, Z. A.; Mohammed, S. I. Association of Disease Duration and Duration of Olanzapine Use With Blood Sugar, Blood Pressure, BMI, and Lipid Profile Among Schizophrenic Patients in Iraq. Al-Rafidain J Med Sci 2023, 4, 79-85.